You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?

https://doi.org/10.1136/jclinpath-2013-201483

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors JL-K, LSK, RR-H, PG, LLH, TS, HH have contributed significantly to the present manuscript and the underlying laboratory work/interpretation of the results.

    • Competing interests Aarhus University has filed a patent application concerning the Competitive Amplification of Differentially Melting Amplicons (CADMA) methodology with LSK, HH and LLH listed as inventors.

    • Provenance and peer review Not commissioned; internally peer reviewed.